In summary, the associations of circulating FGF-23 concentration with parameters of glucose metabolism, bone density and atherosclerosis are dependent on iron and obesity status-associated insulin resistance. The gene discussed is FGF23; the disease is obesity due to melanocortin 4 receptor deficiency.